Ads by Google
Scientists have found that a defect in the beta cells that make and release insulin has implications for the failure of these cells and the development of type 2 diabetes.
Researchers have discovered that a significant portion of people who have had type 1 diabetes for 50 or more years still have the capacity to produce insulin, a finding that has potential implications for improved treatment for all with the disease.
New research shows that there is a link between diabetes and depression. If you have diabetes you may get depressed, but if you are suffering from depression you may get diabetes.
Diabetics may soon be able to lead an insulin-free life as a new study revealed that oral medications can replace the hormone shots.
Hearing loss is about twice as common in adults with diabetes compared to those who do not have the disease.
Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications.
This study also showed that patients who switched from BYETTA injection after 30 weeks to exenatide once weekly experienced additional improvements in A1C and fasting plasma glucose.
Synvista Therapeutics announced data from three Phase 2 trials of SYI-2074 in Type 2 diabetic patients.
Sanford Health leaders announced the focus of the Sanford Project is curing type 1 diabetes via the body's natural ability to regenerate beta cells. Identified as the attack on one of the greatest health concerns of our time, Sanford Health is dedicating health research resources to cure type 1 diabetes, also known as juvenile diabetes.
New results from the world's largest ever study of diabetes treatments show that intensive blood glucose control using modified release gliclazide and other drugs as required, protects patients against serious complications of the disease.
At the 68th Scientific Sessions of the American Diabetes Association in San Francisco several studies were presented evaluating the impact of blood sugar control to reduce diabetes-related complications in patients.
KineMed and Daiichi Sankyo announced that researchers have discovered a key difference in bile acid metabolism in people with type 2 diabetes which may suggest a newly identified underlying disorder.
Microspheres carrying targeted nucleic acid molecules fabricated in the laboratory have been shown to prevent and even reverse new-onset cases of type 1 diabetes in animal models. The results of these studies were reported by diabetes researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and Baxter Healthcare Corporation.
Ethicon added cancer related warning to Regranex adding an Important Safety Information do its diabetes foot ulcer treatment gel.
Clinical study in the search for diabetes treatment shows that liraglutide provides statistically significantly better blood glucose control than exenatide.
Licensed pesticide applicators who used chlorinated pesticides on more than 100 days in their lifetime were at greater risk of diabetes.
Addition of Welchol, (colesevelam HCl) to common diabetes treatment regimens can lower A1C in patients with type 2 diabetes mellitus by 1% or greater.
The new animal model's regenerative ability may provide future insights into improved treatments of diabetes, which affects millions of Americans suffering from diabetes.
Subjects with type 1 or type 2 diabetes who self-monitor their blood glucose levels more frequently and use the results to adjust treatment regimens can achieve improved glucose control.
The risk of developing type 2 diabetes in women is significantly increased as a result of either low cardiorespiratory fitness or higher Body Mass Index (BMI), and a combination of the two increases the risk the most.
Microscopic spheres carrying molecules synthesized in a laboratory have been shown to prevent and even reverse new-onset cases of type 1 diabetes in animal models.
Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their antihypertensive medication and improves cardiovascular disease risk factors.
Researchers who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.
For people with diabetes, high blood pressure poses a special threat, multiplying their risk of heart attacks, strokes and kidney problems.
In a Phase 3 human clinical trial, Spherix is currently studying the efficacy and safety of Naturlose for the treatment of diabetes.
Scientists demonstrate for the first time in a mouse model that skeletal muscle cells cultured in a low-calorie environment refrain from differentiating, an energy-demanding process by which cells mature and specialize.
It has long been known that type 2 diabetes is linked to obesity, particularly fat inside the belly. Now, researchers at the Joslin Diabetes Center have found that fat from other areas of the body can actually reduce insulin resistance and improve insulin sensitivity.
In a study published in the May issue of Cell Metabolism, a team lead by C. Ronald Kahn, M.D. found that subcutaneous fat -- fat found below the skin, usually in the hips and thighs -- is associated with reduced insulin levels and improved insulin sensitivity.
A new study examining the dose accuracy of the SoloSTAR disposable insulin pen for diabetes patients, prefilled with Lantus or Apidra, found the pens accurately delivered all insulin doses within standard limits defined by the ISO.
Teens with Type 1 Diabetes often use Insulin pumps as part of treating the disease but an FDA study shows the device has been linked to injuries and a few deaths.
University of Michigan researchers have new clues to what goes awry at the cellular level in type 2 diabetes.
